HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: M600005-JLR200v1 47/7/1366    most recent Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Castellani, L. W. Articles by Reynolds, W. F. Search for Related Content PubMed PubMed Citation Articles by Castellani, L. W. Articles by Reynolds, W. F. Social Bookmarking                      What's this?

Journal of Lipid Research, Vol. 47, 1366-1377, July 2006
Copyright © 2006 by American Society for Biochemistry and Molecular Biology

Transgenic mice express human MPO –463G/A alleles at atherosclerotic lesions, developing hyperlipidemia and obesity in –463G males

Lawrence W. Castellani^*, James J. Chang, Xuping Wang^*, Aldons J. Lusis^* and Wanda F. Reynolds^1,

^* Departments of Medicine, Microbiology, and Molecular Genetics, University of California-Los Angeles, Los Angeles, CA 90095
Sidney Kimmel Cancer Center, San Diego, CA 92121

Published, JLR Papers in Press, April 25, 2006.

¹ To whom correspondence should be addressed. e-mail: wreynolds{at}skcc.org

Myeloperoxidase (MPO) is an oxidant-generating enzyme present in macrophages at atherosclerotic lesions and implicated in coronary artery disease (CAD). Although mouse models are important for investigating the role of MPO in atherosclerosis, neither mouse MPO nor its oxidation products are detected in lesions in murine models. To circumvent this problem, we generated transgenic mice expressing two functionally different human MPO alleles, with either G or A at position –463, and crossed these to the LDL receptor-deficient (LDLR^–/–) mouse. The –463G allele is linked to higher MPO expression and increased CAD incidence in humans. Both MPO alleles were expressed in a subset of lesions in high-fat-fed LDLR^–/– mice, notably at necrotic lesions with cholesterol clefts. MPOG-expressing LDLR^–/– males (but not females) developed significantly higher serum cholesterol, triglycerides, and glucose, all correlating with increased weight gain/obesity, implicating MPO in lipid homeostasis. The MPOG- and MPOA-expressing LDLR^–/– males also exhibited significantly larger aortic lesions than control LDLR^–/– males. The human MPO transgenic model will facilitate studies of MPO involvement in atherosclerosis and lipid homeostasis.

Supplementary key words myeloperoxidase • atherosclerosis • hyperlipidemia • cholesterol • triglycerides • macrophage

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				S. J. Nicholls and S. L. Hazen Myeloperoxidase, modified lipoproteins, and atherogenesis J. Lipid Res., April 1, 2009; 50(Supplement): S346 - S351. [Abstract] [Full Text] [PDF]

				R. A. Maki, V. A. Tyurin, R. C. Lyon, R. L. Hamilton, S. T. DeKosky, V. E. Kagan, and W. F. Reynolds Aberrant Expression of Myeloperoxidase in Astrocytes Promotes Phospholipid Oxidation and Memory Deficits in a Mouse Model of Alzheimer Disease J. Biol. Chem., January 30, 2009; 284(5): 3158 - 3169. [Abstract] [Full Text] [PDF]